Medical authorities continue to struggle to contain the new Ebola outbreak. Treating the disease with blood plasma donated by Ebola survivors failed to drastically increase the likelihood of recovering from the malady, according to a field test of the experimental treatment. The results are based on the cases of 84 people treated with plasma in […]

Researchers from UW Medicine have discovered a drug-like molecule that can initiate an innate immune response against RNA viruses, like Ebola, hepatitis C and influenza A, by inducing certain genes. The discovery could pave new methods for how disease is treated and prevented in the West. The recent study was published in the Journal of […]

As the New York Times puts it, Big Pharma executive Martin Shkreli “has emerged as a symbol of pharmaceutical greed for acquiring a decades-old drug used to treat an infection that can be devastating for babies and people with AIDS and, overnight, raising the price to $750 a pill from $13.50. His only mistake, he […]

Martin Shkreli, the former hedge fund manager responsible for hiking the price of a drug used to treat infections from $13.50 to $750 per pill, was arrested by federal authorities Thursday morning in his posh “Midtown Manhattan apartment,” and charged with securities fraud, according to a report by The New York Times.(1) Shkreli’s arrest appears […]

A hormone treatment frequently used to help men suffering from prostate cancer may be doubling their risk for developing Alzheimer’s disease, according to new research presented on Monday. The study’s results are so concerning that doctors may now discuss the new information with patients before they choose their treatment. One of the most common cancers […]

Under new legislation already passed by the House, pharmaceutical drugs and medical devices may soon be as loosely regulated as the 80,000+ harmful chemicals allowed in everyday products, most of which are blamed for a majority of America’s chronic illnesses. H.R.6, or the 21st Century Cures Act, essentially weakens the already weak standards for the […]